4 Midcap 5-10 Per Cent Below 52-Week High Stocks to Watch for Future Multibagger Potential: Federal Bank, MCX, Navin Fluorine and Ajanta Pharma

5-10 per cent below 52-week high stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Federal Bank, MCX, Navin Fluorine and Ajanta Pharma meet that test, with market caps from Rs 43,550 crore to Rs 82,902 crore and Federal Bank offering the lowest PE of the group at 15.39. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price 5 to 10 per cent below its 52-week high, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price 5 to 10 per cent below its 52-week high, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening 5-10 per cent below 52-week high stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are 5-10 Per Cent Below 52-Week High Stocks and Why Do They Attract Multibagger Interest?

5-10 per cent below 52-week high stocks are shares that trade just a little under their yearly peak, a sign of strength that shows buyers are still holding on to the stock. The four here cover private banking, commodity exchange services, specialty chemicals and pharmaceuticals.

A stock that stays close to its yearly high while profit keeps growing shows that the market is comfortable with the business and its direction. Within 5-10 per cent below 52-week high stocks, the four companies show rising profit. For 5-10 per cent below 52-week high stocks, both FY26 and the latest quarter showed growth. Whichever way you read 5-10 per cent below 52-week high stocks, the common thread is rising profit backed by complete financial data. For 5-10 per cent below 52-week high stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of 5-10 per cent below 52-week high stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for 5-10 per cent below 52-week high stocks before you decide.

5-10 Per Cent Below 52-Week High Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 28 October 2026. Federal Bank has the lowest PE of the group at 15.39, while MCX posts the highest return on equity at 46.75%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Federal Bank	346	82,902	15.39	11.94	12.60%	2.01	211.52 to 371.70
Multi Commodity Exchange of India	3,180.60	82,353	53.41	42.17	46.75%	28.92	1,762.10 to 3,481.40
Navin Fluorine International	8,501	44,095	55.84	36.42	16.69%	11.09	4,772.20 to 8,949.50
Ajanta Pharma	3,459.80	43,550	38.37	36.35	23.33%	9.62	2,380.20 to 3,796.00

Federal Bank: 22.90% Profit CAGR Since FY22

Federal Bank is a Kerala-based private sector bank with a strong NRI deposit base and a growing retail, small business and digital franchise. It reported FY26 total income of Rs 34,272.42 crore, up 7.00% year on year, and net profit of Rs 4,483.38 crore, up 6.71%. Net profit has compounded at 22.90% a year since FY22, while total income has grown 20.05% a year.

In the September 2026 quarter, total income rose 19.01% to Rs 9,903.41 crore and net profit grew 53.42% to Rs 1,564.06 crore. The share price has gained 259.57% over five years and 57.58% over the past year. Domestic institutions raised their holding from 48.17% in June 2025 to 49.28% in June 2026. The stock trades at a PE of 15.39 against an industry PE of 11.94, with a return on equity of 12.60%.

MCX: 74.55% Profit CAGR Since FY22

MCX is India's leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 53.41 against an industry PE of 42.17, with a return on equity of 46.75%. In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026.

Navin Fluorine: 26.02% Profit CAGR Since FY22

Navin Fluorine International makes specialty fluorochemicals, refrigerant gases and contract research and manufacturing services. It reported FY26 revenue of Rs 3,379.19 crore, up 41.20% year on year, and net profit of Rs 663.56 crore, up 129.92%. Net profit has compounded at 26.02% a year since FY22, while revenue has grown 22.66% a year. Operating margin was 34.41% in FY26. The debt-to-equity ratio is 0.32.

In the June 2026 quarter, revenue rose 46.11% to Rs 1,080.17 crore and net profit grew 107.66% to Rs 243.31 crore. The share price has gained 111.47% over five years and 61.62% over the past year. Foreign investors raised their holding from 21.98% in July 2025 to 23.73% in June 2026. The stock trades at a PE of 55.84 against an industry PE of 36.42, with a return on equity of 16.69%.

Ajanta Pharma: Return on Equity of 23.33%

Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

The stock trades at a PE of 38.37 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.

5-10 Per Cent Below 52-Week High Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these 5-10 per cent below 52-week high stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Total Income (Rs Cr)	Net Profit (Rs Cr)	Income Growth (YoY)	4-Year Income CAGR	4-Year Net Profit CAGR
Federal Bank	34,272.42	4,483.38	7.00%	20.05%	22.90%
MCX	2,429.05	1,331.55	100.94%	53.87%	74.55%
Navin Fluorine	3,379.19	663.56	41.20%	22.66%	26.02%
Ajanta Pharma	5,624.93	1,056	18.60%	12.94%	10.33%

Check the Univest Screener for live data on these 5-10 per cent below 52-week high stocks

Institutional Holding in Federal Bank, MCX, Navin Fluorine and Ajanta Pharma

Institutional holding shows who is backing these 5-10 per cent below 52-week high stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in Federal Bank (from 48.17% to 49.28%) and Ajanta Pharma (from 17.90% to 21.94%).

Stock	Promoter	FII	DII	Public	Quarter
Federal Bank	Nil	27.71%	49.28%	23.01%	June 2026
MCX	Nil	29.84%	50.81%	19.34%	June 2026
Navin Fluorine	27.08%	23.73%	28.46%	20.73%	June 2026
Ajanta Pharma	63.47%	7.63%	21.94%	6.96%	September 2026

Risks to Weigh in 5-10 Per Cent Below 52-Week High Stocks

Being careful with 5-10 per cent below 52-week high stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Navin Fluorine trades at a PE of 55.84 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between 5-10 Per Cent Below 52-Week High Stocks

Picking from 5-10 per cent below 52-week high stocks comes down to four checks, applied in order.

1. Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
2. Compare each PE with the industry PE (11.94 to 42.17) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Federal Bank, MCX, Navin Fluorine and Ajanta Pharma live prices.

Conclusion

Among 5-10 per cent below 52-week high stocks, Federal Bank stands out for the lowest PE of the group at 15.39, MCX for the highest return on equity at 46.75%, Navin Fluorine for the strongest latest-quarter profit growth at 107.66% and Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing 5-10 per cent below 52-week high stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on 5-10 Per Cent Below 52-Week High Stocks to Watch

Which are the best 5-10 per cent below 52-week high stocks to watch for multibagger potential?

Ans. Federal Bank, MCX, Navin Fluorine and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 82,902 crore, Rs 82,353 crore, Rs 44,095 crore and Rs 43,550 crore respectively. Federal Bank is notable for the lowest PE of the group at 15.39. MCX stands out for the highest return on equity at 46.75%. Navin Fluorine offers the strongest latest-quarter profit growth at 107.66%. Ajanta Pharma brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for 5-10 per cent below 52-week high stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is MCX a good stock for long-term investors?

Ans. MCX has a return on equity of 46.75%, a PE of 53.41 against an industry PE of 42.17 and a market cap of Rs 82,353 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in 5-10 per cent below 52-week high stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Navin Fluorine become a multibagger from here?

Ans. Navin Fluorine has already gained 111.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in 5-10 per cent below 52-week high stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.02% a year since FY22, and FY26 revenue rose 41.20%. At a PE of 55.84 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Federal Bank, MCX, Navin Fluorine and Ajanta Pharma?

Ans. As of 28 October 2026, Federal Bank has a market cap of Rs 82,902 crore, MCX has a market cap of Rs 82,353 crore, Navin Fluorine has a market cap of Rs 44,095 crore and Ajanta Pharma has a market cap of Rs 43,550 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on 5-10 per cent below 52-week high stocks.

What are the risks of investing in 5-10 per cent below 52-week high stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Navin Fluorine trades at a PE of 55.84 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Navin Fluorine trading at a PE of 55.84?

Ans. Navin Fluorine's PE of 55.84 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.69%, profit growth of 26.02% a year since FY22 and latest-quarter profit growth of 107.66%, which also means the stock is more sensitive if growth slows. Investors in 5-10 per cent below 52-week high stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Federal Bank, MCX, Navin Fluorine and Ajanta Pharma?

Ans. As of the latest reported quarter, FII and DII together hold 76.99% of Federal Bank (27.71% and 49.28%), 80.65% of MCX (29.84% and 50.81%), 52.19% of Navin Fluorine (23.73% and 28.46%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in 5-10 per cent below 52-week high stocks, though it should be read with earnings trends rather than on its own.